Further evidence that indorenate is a 5-HT1 agonist.
Benítez-King
G
G
Depto. de Neurofarmacología, Instituto Mexicano de Psiquiatría.
Chávez
J L
JL
Martínez
I
I
Antón-Tay
F
F
Hong
E
E
D008735:5-Methoxytryptamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001667:Binding, Competitive / Q000187:drug effects; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008566:Membranes / Q000187:drug effects / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000187:drug effects*; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
D000959:Antihypertensive Agents; D011743:Pyrimidines; D011985:Receptors, Serotonin; D013764:Tetrahydronaphthalenes; D008735:5-Methoxytryptamine; C043077:ipsapirone; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D006160:Guanosine Triphosphate; C033600:indorenate; D011188:Potassium